NOT FOR REPRINT
Biosimilars can help get autoimmune drug costs under control
Commentary September 04, 2026 at 07:37 AM
Share & Print
What You Need To Know
- Targeted immunomodulators fight conditions that are hard to manage, like psoriasis and Crohn's disease.
- Some have wondered whether the arrival of biosimilars would make a difference.
- Adalimumab biosimilars cut spending on that type of drug by 73%.
More From HR Executive
NOT FOR REPRINT
© Arc, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.